|
G |
Ace |
angiotensin I converting enzyme |
multiple interactions |
EXP |
Lycopene inhibits the reaction [bisphenol A results in decreased activity of ACE protein] |
CTD |
PMID:32153214 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
Lycopene inhibits the reaction [manganese chloride results in increased activity of ACHE protein]; Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of ACHE protein] |
CTD |
PMID:22192907 PMID:26900785 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acvr2b |
activin A receptor type 2B |
decreases expression |
EXP |
Lycopene results in decreased expression of SCGB2A2 mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
|
|
G |
Add1 |
adducin 1 |
decreases expression |
ISO |
lycopene results in decreased expression of ADD1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
multiple interactions |
ISO |
lycopene inhibits the reaction [HMGB1 protein results in increased expression of AGER protein]; lycopene inhibits the reaction [Lipopolysaccharides results in increased expression of AGER protein] |
CTD |
PMID:22429818 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases expression multiple interactions |
ISO |
lycopene results in decreased expression of AHR mRNA [Lycopene co-treated with Atrazine] results in increased expression of AHR mRNA; Lycopene inhibits the reaction [Atrazine results in increased expression of AHR protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of AHR mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and results in increased localization of AHR protein] |
CTD |
PMID:16886892 PMID:36216167 PMID:36403809 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
lycopene inhibits the reaction [Galactose results in increased expression of AIF1 protein] |
CTD |
PMID:28974442 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
lycopene results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:17337101 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions |
ISO EXP |
lycopene inhibits the reaction [Zearalenone results in decreased activity of ALAD protein] lycopene inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein] |
CTD |
PMID:17516994 PMID:25682699 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Andpro |
androgen regulated protein |
decreases expression |
EXP |
lycopene results in decreased expression of ANDPRO mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966
|
|
G |
Aqp1 |
aquaporin 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of AQP1 mRNA] |
CTD |
PMID:33960999 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp11 |
aquaporin 11 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of AQP11 mRNA] |
CTD |
PMID:33960999 |
|
NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725
|
|
G |
Aqp2 |
aquaporin 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of AQP2 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of AQP2 protein] |
CTD |
PMID:33960999 |
|
NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:130,711,413...130,716,468
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of AQP4 mRNA] |
CTD |
PMID:33960999 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Aqp6 |
aquaporin 6 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of AQP6 mRNA] |
CTD |
PMID:33960999 |
|
NCBI chr 7:130,732,216...130,735,149
Ensembl chr 7:130,633,579...130,735,194 Ensembl chr 7:130,633,579...130,735,194
|
|
G |
Aqp7 |
aquaporin 7 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of AQP7 mRNA] |
CTD |
PMID:33960999 |
|
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
|
|
G |
Ar |
androgen receptor |
decreases expression |
ISO |
lycopene results in decreased expression of AR mRNA |
CTD |
PMID:16886892 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
increases expression multiple interactions |
ISO |
Lycopene results in increased expression of ARNT mRNA Lycopene inhibits the reaction [Atrazine results in increased expression of ARNT mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ARNT mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ARNT protein] |
CTD |
PMID:36216167 PMID:36403809 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA] |
CTD |
PMID:32544411 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg10 |
autophagy related 10 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG10 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233
|
|
G |
Atg13 |
autophagy related 13 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of ATG13 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
|
|
G |
Atg14 |
autophagy related 14 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of ATG14 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr15:20,795,750...20,827,113
Ensembl chr15:20,795,750...20,827,113
|
|
G |
Atg16l1 |
autophagy related 16-like 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG16L1 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529
|
|
G |
Atg16l2 |
autophagy related 16-like 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of ATG16L2 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420
|
|
G |
Atg2b |
autophagy related 2B |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of ATG2B mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
|
|
G |
Atg3 |
autophagy related 3 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG3 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Atg4a |
autophagy related 4A, cysteine peptidase |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG4A mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr X:104,665,345...104,765,271
Ensembl chr X:104,665,345...104,765,268
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of ATG4B mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
|
|
G |
Atg4c |
autophagy related 4C, cysteine peptidase |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG4C mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 5:113,867,218...113,935,534
Ensembl chr 5:113,867,092...113,934,830
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
ISO EXP |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG5 mRNA] [Glucose co-treated with Lycopene] results in increased expression of ATG5 mRNA |
CTD |
PMID:30360616 PMID:38444079 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of ATG7 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atg9a |
autophagy related 9A |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of ATG9A mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 9:76,677,403...76,688,050
Ensembl chr 9:76,677,404...76,687,986
|
|
G |
Atg9b |
autophagy related 9B |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of ATG9B mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 4:10,784,934...10,793,832
Ensembl chr 4:10,786,114...10,793,651
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine affects the expression of ATP1A1 mRNA]; Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1A1 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of ATP1A1 mRNA] |
CTD |
PMID:26476475 PMID:27112537 PMID:33960999 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1A2 mRNA] |
CTD |
PMID:27112537 PMID:33960999 |
|
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
multiple interactions |
ISO |
lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1A3 mRNA] |
CTD |
PMID:26476475 |
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Atp1a4 |
ATPase Na+/K+ transporting subunit alpha 4 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine affects the expression of ATP1A4 mRNA] |
CTD |
PMID:26476475 PMID:27112537 |
|
NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1B1 mRNA] |
CTD |
PMID:27112537 PMID:33960999 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine affects the expression of ATP1B2 mRNA]; Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1B2 mRNA] |
CTD |
PMID:26476475 PMID:27112537 PMID:33960999 |
|
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
|
|
G |
Atp1b3 |
ATPase Na+/K+ transporting subunit beta 3 |
multiple interactions |
ISO |
lycopene inhibits the reaction [Atrazine affects the expression of ATP1B3 mRNA] |
CTD |
PMID:26476475 |
|
NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:96,910,309...96,941,598 Ensembl chr 8:96,910,309...96,941,598
|
|
G |
Atp1b4 |
ATPase Na+/K+ transporting family member beta 4 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1B4 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of ATP1B4 mRNA] |
CTD |
PMID:26476475 PMID:33960999 |
|
NCBI chr X:117,087,284...117,108,023
Ensembl chr X:117,057,423...117,108,020
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine affects the expression of ATP2A1 mRNA] |
CTD |
PMID:27112537 |
|
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine affects the expression of ATP2A2 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of ATP2A2 mRNA] |
CTD |
PMID:27112537 PMID:33960999 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp2a3 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP2A3 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of ATP2A3 mRNA] |
CTD |
PMID:26476475 PMID:27112537 PMID:33960999 |
|
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine affects the expression of ATP2B1 mRNA]; Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP2B1 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of ATP2B1 mRNA] |
CTD |
PMID:26476475 PMID:27112537 PMID:33960999 |
|
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
|
|
G |
Atp2b2 |
ATPase plasma membrane Ca2+ transporting 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP2B2 mRNA] |
CTD |
PMID:26476475 PMID:27112537 |
|
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
|
|
G |
Atp2b3 |
ATPase plasma membrane Ca2+ transporting 3 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP2B3 mRNA] |
CTD |
PMID:26476475 PMID:27112537 |
|
NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775
|
|
G |
Atp2b4 |
ATPase plasma membrane Ca2+ transporting 4 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine affects the expression of ATP2B4 mRNA] |
CTD |
PMID:26476475 PMID:27112537 |
|
NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
|
|
G |
Atp2c1 |
ATPase secretory pathway Ca2+ transporting 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP2C1 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of ATP2C1 mRNA] |
CTD |
PMID:26476475 PMID:27112537 PMID:33960999 |
|
NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006
|
|
G |
Atp2c2 |
ATPase secretory pathway Ca2+ transporting 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine affects the expression of ATP2C2 mRNA]; Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP2C2 mRNA] |
CTD |
PMID:26476475 PMID:27112537 PMID:33960999 |
|
NCBI chr19:47,754,120...47,811,369
Ensembl chr19:47,754,120...47,811,368
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
increases expression |
ISO |
lycopene results in increased expression of BACH1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of BAK1 protein] |
CTD |
PMID:36583613 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
increases expression |
ISO |
lycopene results in increased expression of BAP1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO EXP |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of BAX mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of BAX protein]; Lycopene inhibits the reaction [Sodium Fluoride results in increased expression of BAX mRNA] Lycopene inhibits the reaction [Benzo(a)pyrene results in increased expression of BAX mRNA]; Lycopene inhibits the reaction [Benzo(a)pyrene results in increased expression of BAX protein]; Lycopene inhibits the reaction [bisphenol A results in increased expression of BAX mRNA]; Lycopene inhibits the reaction [Sodium Fluoride results in increased expression of BAX mRNA]; Lycopene inhibits the reaction [Sodium Glutamate results in increased expression of BAX mRNA] |
CTD |
PMID:26900785 PMID:27871895 PMID:31568845 PMID:32153214 PMID:36583613 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of BCHE protein] |
CTD |
PMID:26900785 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
EXP ISO |
[Glucose co-treated with Lycopene] results in increased expression of BCL2 mRNA; [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; Lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; Lycopene inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 mRNA]; Lycopene inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]; Lycopene inhibits the reaction [bisphenol A results in decreased expression of BCL2 mRNA]; Lycopene inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA]; Lycopene inhibits the reaction [Sodium Glutamate results in decreased expression of BCL2 mRNA] lycopene inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA] Lycopene results in increased expression of BCL2 mRNA |
CTD |
PMID:16030430 PMID:26900785 PMID:27871895 PMID:31568845 PMID:32153214 PMID:38444079 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bco1 |
beta-carotene oxygenase 1 |
multiple interactions |
ISO |
BCO1 affects the reaction [lycopene results in decreased abundance of Testosterone] |
CTD |
PMID:21935922 |
|
NCBI chr19:45,149,250...45,186,102
Ensembl chr19:45,149,265...45,186,101
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO EXP |
Lycopene inhibits the reaction [Galactose results in decreased expression of BDNF mRNA]; Lycopene inhibits the reaction [Galactose results in decreased expression of BDNF protein] Lycopene inhibits the reaction [bisphenol A results in decreased expression of BDNF protein]; Lycopene inhibits the reaction [Oxaliplatin results in decreased expression of BDNF protein] |
CTD |
PMID:28974442 PMID:32153214 PMID:32544411 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO EXP |
Lycopene inhibits the reaction [Atrazine results in increased expression of BECN1 mRNA] [Glucose co-treated with Lycopene] results in increased expression of BECN1 mRNA |
CTD |
PMID:30360616 PMID:38444079 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
lycopene results in decreased expression of BRAF protein |
CTD |
PMID:17337101 |
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
ISO |
lycopene results in decreased expression of C1QA mRNA |
CTD |
PMID:19555370 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C4b |
complement C4B |
decreases expression |
ISO |
lycopene results in decreased expression of C4B mRNA |
CTD |
PMID:19555370 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of CALCA protein] |
CTD |
PMID:33592256 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CASP1 protein] |
CTD |
PMID:36610486 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP ISO |
[Glucose co-treated with Lycopene] results in increased expression of CASP3 mRNA; [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP3 protein]; Lycopene inhibits the reaction [Atrazine results in increased expression of CASP3 mRNA]; Lycopene inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP3 protein]; Lycopene inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; Lycopene inhibits the reaction [Oxaliplatin results in increased expression of CASP3 protein]; Lycopene inhibits the reaction [Sodium Fluoride results in increased activity of CASP3 protein]; Lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP3 mRNA] Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CASP3 protein]; Lycopene inhibits the reaction [Sodium Fluoride results in increased activity of CASP3 protein]; Lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP3 mRNA] |
CTD |
PMID:16030430 PMID:27102619 PMID:27871895 PMID:31568845 PMID:32153214 PMID:32544411 PMID:36583613 PMID:38444079 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions decreases expression |
EXP ISO |
[Glucose co-treated with Lycopene] results in increased expression of CASP8 mRNA; [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein]; Lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] lycopene results in decreased expression of CASP8 mRNA |
CTD |
PMID:16030430 PMID:16886892 PMID:38444079 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP ISO |
[Glucose co-treated with Lycopene] results in increased expression of CASP9 mRNA; Lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP9 mRNA] lycopene inhibits the reaction [Sodium Fluoride results in increased activity of CASP9 protein]; lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP9 mRNA] |
CTD |
PMID:27871895 PMID:38444079 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases expression increases activity decreases expression |
EXP ISO |
Lycopene affects the reaction [Doxorubicin affects the activity of CAT protein]; Lycopene inhibits the reaction [Atrazine results in decreased activity of CAT protein]; Lycopene inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]; Lycopene inhibits the reaction [Cadmium Chloride results in increased activity of CAT protein]; Lycopene inhibits the reaction [Mercuric Chloride results in increased activity of CAT protein]; Lycopene inhibits the reaction [Oxaliplatin results in decreased activity of CAT protein]; Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of CAT protein]; Lycopene inhibits the reaction [Sodium Glutamate results in increased expression of CAT mRNA] lycopene results in increased expression of CAT lycopene results in increased activity of CAT protein Lycopene affects the reaction [Atrazine affects the expression of CAT mRNA]; Lycopene inhibits the reaction [Acetaminophen results in increased activity of CAT protein]; Lycopene inhibits the reaction [Atrazine results in decreased activity of CAT protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CAT mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CAT protein] Lycopene results in decreased expression of CAT mRNA |
CTD |
PMID:16325981 PMID:17516994 PMID:17873360 PMID:19450652 PMID:20074268 PMID:26900785 PMID:27102619 PMID:27989599 PMID:30360616 PMID:31568845 PMID:32544411 PMID:35917956 PMID:36216167 PMID:36610486 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CCL4 mRNA] |
CTD |
PMID:36583613 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CCL5 mRNA] |
CTD |
PMID:36583613 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO EXP |
lycopene inhibits the reaction [Genistein results in increased expression of CCND1 protein]; lycopene inhibits the reaction [IGF1 protein results in increased expression of CCND1 protein] lycopene inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased expression of CCND1 protein] lycopene results in decreased expression of CCND1 protein |
CTD |
PMID:16565789 PMID:17051425 PMID:17337101 PMID:19551842 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression increases expression |
ISO |
lycopene results in decreased expression of CCNE1 protein lycopene results in increased expression of CCNE1 mRNA |
CTD |
PMID:16886892 PMID:17337101 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
increases expression multiple interactions |
EXP |
Lycopene results in increased expression of CCS mRNA [Glucose co-treated with Lycopene] results in increased expression of CCS mRNA |
CTD |
PMID:38444079 |
|
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
lycopene results in decreased expression of CDK1 protein |
CTD |
PMID:17337101 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
lycopene results in decreased expression of CDK4 protein |
CTD |
PMID:17337101 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
decreases expression |
ISO |
lycopene results in decreased expression of CDK5 protein |
CTD |
PMID:17337101 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdk7 |
cyclin-dependent kinase 7 |
decreases expression |
ISO |
lycopene results in decreased expression of CDK7 protein |
CTD |
PMID:17337101 |
|
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
|
|
G |
Cdk9 |
cyclin-dependent kinase 9 |
decreases expression |
ISO |
lycopene results in decreased expression of CDK9 protein |
CTD |
PMID:17337101 |
|
NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
lycopene inhibits the reaction [IGF1 protein results in increased expression of CDKN1A protein] |
CTD |
PMID:16565789 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cgas |
cyclic GMP-AMP synthase |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CGAS mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CGAS protein] |
CTD |
PMID:36583613 |
|
NCBI chr 8:79,292,282...79,306,998
Ensembl chr 8:79,294,511...79,305,496
|
|
G |
Chga |
chromogranin A |
increases expression |
ISO |
lycopene results in increased expression of CHGA mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
|
|
G |
Chgb |
chromogranin B |
decreases expression |
ISO |
lycopene results in decreased expression of CHGB mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
|
|
G |
Ckb |
creatine kinase B |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of CKB protein] |
CTD |
PMID:26900785 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Crb1 |
crumbs cell polarity complex component 1 |
decreases expression |
ISO |
lycopene results in decreased expression of CRB1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr13:50,801,484...50,989,261
Ensembl chr13:50,800,959...50,989,261
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions increases expression |
EXP |
Lycopene inhibits the reaction [bisphenol A results in decreased expression of CREB1 protein] Lycopene results in increased expression of CREB1 protein |
CTD |
PMID:32153214 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CSF2 mRNA] |
CTD |
PMID:36583613 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctss |
cathepsin S |
decreases expression |
ISO |
lycopene results in decreased expression of CTSS mRNA |
CTD |
PMID:19555370 |
|
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CXCL10 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CXCL10 protein] |
CTD |
PMID:36583613 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
decreases expression |
ISO |
lycopene results in decreased expression of CXCL14 mRNA |
CTD |
PMID:19555370 |
|
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CXCL2 mRNA] |
CTD |
PMID:36583613 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions |
ISO |
lycopene inhibits the reaction [Atrazine results in increased expression of CYB5A protein] |
CTD |
PMID:26775023 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cygb |
cytoglobin |
increases expression |
EXP |
Lycopene results in increased expression of CYGB mRNA |
CTD |
PMID:38444079 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP11A1 protein] |
CTD |
PMID:19071209 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity multiple interactions |
ISO |
lycopene results in decreased activity of CYP1A1 protein Lycopene inhibits the reaction [Atrazine results in increased expression of CYP1A1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CYP1A1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CYP1A1 protein] |
CTD |
PMID:19329757 PMID:26775023 PMID:36216167 PMID:36403809 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression |
ISO |
[Lycopene co-treated with Atrazine] results in increased expression of CYP1A2 mRNA; Lycopene inhibits the reaction [Atrazine results in increased expression of CYP1A2 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CYP1A2 protein] Lycopene results in increased expression of CYP1A2 mRNA |
CTD |
PMID:26775023 PMID:36216167 PMID:36403809 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity multiple interactions increases expression |
ISO |
lycopene results in decreased activity of CYP1B1 protein [Lycopene co-treated with Atrazine] results in increased expression of CYP1B1 mRNA; Lycopene affects the reaction [Atrazine results in increased expression of CYP1B1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CYP1B1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CYP1B1 protein] Lycopene results in increased expression of CYP1B1 mRNA |
CTD |
PMID:19329757 PMID:26775023 PMID:36216167 PMID:36403809 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
multiple interactions |
ISO |
Lycopene affects the reaction [Atrazine affects the expression of CYP2A4 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of CYP2A4 mRNA] |
CTD |
PMID:26775023 PMID:36216167 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
Lycopene promotes the reaction [Atrazine results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
multiple interactions |
ISO |
Lycopene affects the reaction [Atrazine results in increased expression of CYP2C29 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of CYP2E1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CYP2E1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CYP2E1 protein] |
CTD |
PMID:26775023 PMID:36216167 PMID:36403809 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of CYP2F2 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases activity |
ISO |
Lycopene results in increased activity of CYP3A4 protein |
CTD |
PMID:16632523 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of CYP3A13 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4v3 |
cytochrome P450, family 4, subfamily v, polypeptide 3 |
multiple interactions increases expression |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of CYP4V3 mRNA] Lycopene results in increased expression of CYP4V3 mRNA |
CTD |
PMID:36216167 |
|
NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
multiple interactions |
ISO |
lycopene inhibits the reaction [Atrazine results in increased expression of CYP7B1 mRNA] |
CTD |
PMID:26775023 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Ddb2 |
damage specific DNA binding protein 2 |
increases expression |
ISO |
lycopene results in increased expression of DDB2 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Oxaliplatin results in increased expression of EIF2AK3 mRNA] |
CTD |
PMID:32544411 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
increases expression |
ISO |
lycopene results in increased expression of EIF4G1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Oxaliplatin results in increased expression of ERN1 mRNA] |
CTD |
PMID:32544411 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases expression |
ISO |
lycopene inhibits the reaction [Estradiol results in increased activity of ESR1 protein] lycopene results in increased expression of ESR1 mRNA |
CTD |
PMID:16886892 PMID:17051425 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
lycopene inhibits the reaction [Estradiol results in increased activity of ESR2 protein] |
CTD |
PMID:17051425 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fancc |
FA complementation group C |
decreases expression |
ISO |
lycopene results in decreased expression of FANCC mRNA |
CTD |
PMID:16886892 |
|
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Fancf |
FA complementation group F |
decreases expression |
ISO |
lycopene results in decreased expression of FANCF mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
|
|
G |
Faslg |
Fas ligand |
decreases expression |
ISO |
lycopene results in decreased expression of FASLG mRNA |
CTD |
PMID:16886892 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
lycopene results in increased expression of FOS mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of GCLC mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GCLC mRNA] |
CTD |
PMID:35917956 PMID:36216167 PMID:36610486 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression multiple interactions |
ISO |
Lycopene results in increased expression of GCLM protein Lycopene inhibits the reaction [Atrazine results in increased expression of GCLM mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GCLM mRNA] |
CTD |
PMID:35917956 PMID:36216167 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Get1 |
guided entry of tail-anchored proteins factor 1 |
decreases expression |
ISO |
Lycopene results in decreased expression of GET1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr11:35,438,555...35,460,156
Ensembl chr11:35,445,815...35,459,973
|
|
G |
Gfap |
glial fibrillary acidic protein |
decreases expression multiple interactions |
ISO EXP |
lycopene results in decreased expression of GFAP mRNA Lycopene inhibits the reaction [Oxaliplatin results in increased expression of GFAP protein] |
CTD |
PMID:19555370 PMID:32544411 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression multiple interactions |
ISO EXP |
lycopene results in increased expression of GJA1 protein Lycopene inhibits the reaction [Benzo(a)pyrene results in decreased expression of GJA1 protein] |
CTD |
PMID:16091010 PMID:31568845 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
decreases expression |
ISO |
lycopene results in decreased expression of GJA4 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
decreases expression increases expression |
ISO |
lycopene results in decreased expression of GJA5 mRNA lycopene results in increased expression of GJA5 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO EXP |
Lycopene inhibits the reaction [Atrazine results in increased expression of GPX1 mRNA] [Glucose co-treated with Lycopene] results in increased expression of GPX1 mRNA Lycopene results in increased expression of GPX1 mRNA |
CTD |
PMID:36216167 PMID:38444079 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of GPX2 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression multiple interactions |
ISO |
Lycopene results in increased expression of GPX3 mRNA Lycopene affects the reaction [Atrazine affects the expression of GPX3 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression multiple interactions |
ISO |
lycopene results in decreased expression of GPX4 mRNA Lycopene affects the reaction [Atrazine affects the expression of GPX4 mRNA] |
CTD |
PMID:16886892 PMID:36216167 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gpx5 |
glutathione peroxidase 5 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of GPX5 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr17:43,436,126...43,443,074
Ensembl chr17:43,416,340...43,443,074
|
|
G |
Gpx6 |
glutathione peroxidase 6 |
increases expression |
ISO |
Lycopene results in increased expression of GPX6 mRNA |
CTD |
PMID:36216167 |
|
NCBI chr17:43,408,472...43,416,091
Ensembl chr17:43,408,472...43,416,091
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
increases expression multiple interactions |
ISO |
Lycopene results in increased expression of GPX7 mRNA Lycopene inhibits the reaction [Atrazine results in increased expression of GPX7 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
G |
Gpx8 |
glutathione peroxidase 8 |
increases expression multiple interactions |
ISO |
Lycopene results in increased expression of GPX8 mRNA Lycopene inhibits the reaction [Atrazine results in decreased expression of GPX8 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr 2:44,676,448...44,680,042
Ensembl chr 2:44,676,454...44,680,195
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GSDMD protein] |
CTD |
PMID:36610486 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
lycopene inhibits the reaction [Zearalenone results in decreased activity of GSR protein] |
CTD |
PMID:25682699 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GSS mRNA] |
CTD |
PMID:35917956 PMID:36610486 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions increases expression |
EXP |
[Glucose co-treated with Lycopene] results in increased expression of GSTP1 mRNA Lycopene results in increased expression of GSTP1 mRNA |
CTD |
PMID:38444079 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions decreases response to substance |
ISO |
lycopene inhibits the reaction [HMGB1 protein results in increased expression of AGER protein]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of PLA2G2A protein]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of TNF protein]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of ICAM1 mRNA]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of ICAM1 protein]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of SELE mRNA]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of SELE protein]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of TLR2 protein]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of TLR4 protein]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 mRNA]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 protein]; lycopene inhibits the reaction [Lipopolysaccharides results in increased secretion of HMGB1 protein] lycopene results in decreased susceptibility to HMGB1 protein |
CTD |
PMID:22429818 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
EXP ISO |
lycopene results in increased expression of HMOX1 mRNA; lycopene results in increased expression of HMOX1 protein lycopene promotes the reaction [Atrazine results in increased expression of HMOX1 mRNA] [lycopene co-treated with Hydrogen Peroxide] results in increased expression of HMOX1 protein Lycopene inhibits the reaction [Atrazine results in increased expression of HMOX1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HMOX1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of HMOX1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of HMOX1 protein]; Lycopene inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA] |
CTD |
PMID:19551842 PMID:27102619 PMID:28974442 PMID:30360616 PMID:35917956 PMID:36216167 PMID:36610486 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
EXP |
lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of HSD3B1 protein] |
CTD |
PMID:19071209 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
multiple interactions |
EXP |
lycopene inhibits the reaction [decamethrin results in increased expression of HSPA4 mRNA] |
CTD |
PMID:23076637 |
|
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Oxaliplatin results in increased expression of HSPA5 mRNA] |
CTD |
PMID:32544411 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of ICAM1 mRNA]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of ICAM1 protein]; lycopene inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] |
CTD |
PMID:22429818 PMID:25551565 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
lycopene inhibits the reaction [IGF1 protein results in increased expression of CCND1 protein]; lycopene inhibits the reaction [IGF1 protein results in increased expression of CDKN1A protein]; lycopene inhibits the reaction [IGF1 protein results in increased phosphorylation of RB1 protein] lycopene results in decreased expression of IGF1 mRNA lycopene results in increased expression of IGF1 mRNA |
CTD |
PMID:15084515 PMID:16565789 PMID:16886892 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
decreases expression |
ISO |
lycopene results in decreased expression of IGF1R protein |
CTD |
PMID:17337101 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
ISO |
lycopene results in increased expression of IGFBP2 protein |
CTD |
PMID:17337101 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; lycopene promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] Lycopene inhibits the reaction [Atrazine results in decreased expression of IL10 protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL10 protein]; Lycopene inhibits the reaction [Zearalenone results in increased expression of IL10] |
CTD |
PMID:25551565 PMID:25682699 PMID:36216167 PMID:36583613 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL18 protein] |
CTD |
PMID:36610486 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of IL1B mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL1B mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL1B protein]; Lycopene inhibits the reaction [Galactose results in increased expression of IL1B protein]; Lycopene inhibits the reaction [Zearalenone results in increased expression of IL1B] |
CTD |
PMID:25682699 PMID:28974442 PMID:36216167 PMID:36610486 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
lycopene inhibits the reaction [Zearalenone results in increased expression of IL2] |
CTD |
PMID:25682699 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
EXP ISO |
lycopene results in decreased expression of IL6 mRNA Lycopene inhibits the reaction [Atrazine results in increased expression of IL6 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of IL6 protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL6 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL6 protein]; Lycopene inhibits the reaction [Zearalenone results in increased expression of IL6] |
CTD |
PMID:15084515 PMID:25682699 PMID:36216167 PMID:36583613 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IRF3 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased phosphorylation of IRF3 protein] |
CTD |
PMID:36583613 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Irf7 |
interferon regulatory factor 7 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IRF7 mRNA] |
CTD |
PMID:36583613 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Ivl |
involucrin |
decreases expression |
ISO |
lycopene results in decreased expression of IVL protein |
CTD |
PMID:10769631 |
|
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
|
|
G |
Jak1 |
Janus kinase 1 |
increases expression |
ISO |
lycopene results in increased expression of JAK1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
lycopene results in decreased expression of JUN mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions increases expression |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of KEAP1 mRNA]; Lycopene inhibits the reaction [Atrazine results in decreased expression of KEAP1 protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of KEAP1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of KEAP1 protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of KEAP1 protein] Lycopene results in increased expression of KEAP1 mRNA |
CTD |
PMID:30360616 PMID:35917956 PMID:36216167 PMID:36610486 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kif2a |
kinesin family member 2A |
increases expression |
ISO |
lycopene results in increased expression of KIF2A mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 2:38,367,998...38,431,237
Ensembl chr 2:38,367,998...38,431,508
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
increases expression |
ISO |
lycopene results in increased expression of KPNA2 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression |
ISO |
lycopene results in increased expression of LDLR mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lipa |
lipase A, lysosomal acid type |
increases expression |
ISO |
lycopene results in increased expression of LIPA mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
|
|
G |
Lpo |
lactoperoxidase |
multiple interactions |
ISO |
lycopene inhibits the reaction [Diethylnitrosamine results in increased expression of LPO protein] |
CTD |
PMID:24144777 |
|
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO EXP |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased localization of MAP1LC3B protein] [Glucose co-treated with Lycopene] results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:36583613 PMID:38444079 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
increases expression |
ISO |
lycopene results in increased expression of MAP2K1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
decreases expression |
ISO |
lycopene results in decreased expression of MAP2K2 protein |
CTD |
PMID:17337101 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
decreases expression |
ISO |
lycopene results in decreased expression of MAP2K4 protein |
CTD |
PMID:17337101 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
decreases expression |
ISO |
lycopene results in decreased expression of MAP2K6 protein |
CTD |
PMID:17337101 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases expression |
EXP ISO |
Lycopene inhibits the reaction [[Dietary Fats co-treated with Diethylnitrosamine] results in increased phosphorylation of MAPK1 protein]; Lycopene inhibits the reaction [bisphenol A results in decreased expression of MAPK1 protein] Lycopene inhibits the reaction [Atrazine results in increased expression of MAPK1 mRNA] Lycopene results in increased expression of MAPK1 protein |
CTD |
PMID:19551842 PMID:30360616 PMID:32153214 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
decreases expression increases expression multiple interactions |
ISO EXP |
lycopene results in decreased expression of MAPK14 protein lycopene results in increased expression of MAPK14 mRNA Lycopene inhibits the reaction [Oxaliplatin results in increased expression of MAPK14 protein] |
CTD |
PMID:16886892 PMID:17337101 PMID:32544411 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases expression |
ISO |
lycopene results in decreased expression of MAPK3 protein |
CTD |
PMID:17337101 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases expression |
ISO |
lycopene results in decreased expression of MAPK8 protein |
CTD |
PMID:17337101 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mgat2 |
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
increases expression |
ISO |
lycopene results in increased expression of MGAT2 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177
|
|
G |
Mill1 |
MHC I like leukocyte 1 |
increases expression |
ISO |
Lycopene results in increased expression of MICA mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 1:78,372,798...78,398,932
Ensembl chr 1:78,372,802...78,398,930
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein] |
CTD |
PMID:33592256 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mlh1 |
mutL homolog 1 |
increases expression |
ISO |
lycopene results in increased expression of MLH1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
lycopene inhibits the reaction [Acetaminophen results in increased activity of MMP2 protein] |
CTD |
PMID:27989599 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Msh2 |
mutS homolog 2 |
increases expression |
ISO |
lycopene results in increased expression of MSH2 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh6 |
mutS homolog 6 |
increases expression |
ISO |
lycopene results in increased expression of MSH6 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions |
EXP ISO |
lycopene results in increased expression of NFE2L2 mRNA; lycopene results in increased expression of NFE2L2 protein lycopene promotes the reaction [Atrazine results in increased expression of NFE2L2 mRNA] Lycopene inhibits the reaction [Atrazine affects the localization of NFE2L2 protein]; Lycopene inhibits the reaction [Atrazine results in increased expression of NFE2L2 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of NFE2L2 protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 protein] |
CTD |
PMID:19551842 PMID:27102619 PMID:30360616 PMID:35917956 PMID:36216167 PMID:36610486 More...
|
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
lycopene inhibits the reaction [Atrazine results in increased expression of NFKB1 mRNA] |
CTD |
PMID:27102619 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; lycopene inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA] |
CTD |
PMID:25551565 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NLRP3 protein] |
CTD |
PMID:36610486 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos1 |
nitric oxide synthase 1 |
decreases expression |
ISO |
lycopene results in decreased expression of NOS1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of NQO1 protein]; Lycopene inhibits the reaction [Atrazine results in increased expression of NQO1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NQO1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NQO1 protein]; Lycopene inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA] |
CTD |
PMID:28974442 PMID:30360616 PMID:35917956 PMID:36216167 PMID:36610486 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression |
ISO |
Lycopene increases expression of NR1H3 protein in macrophages |
RGD |
PMID:21208793 |
RGD:401842374 |
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases expression |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of NR1I2 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of NR1I2 protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NR1I2 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NR1I2 protein] Lycopene results in increased expression of NR1I2 mRNA; Lycopene results in increased expression of NR1I2 protein |
CTD |
PMID:36216167 PMID:36403809 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions increases expression |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of NR1I3 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and results in increased localization of NR1I3 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and results in increased localization of NR1I3 protein] Lycopene results in increased expression of NR1I3 mRNA |
CTD |
PMID:36216167 PMID:36403809 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions |
ISO |
[Lycopene co-treated with Atrazine] results in increased expression of NR3C2 mRNA |
CTD |
PMID:36216167 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
increases expression multiple interactions |
EXP |
Lycopene results in increased expression of NTRK2 protein Lycopene inhibits the reaction [bisphenol A results in decreased expression of NTRK2 protein] |
CTD |
PMID:32153214 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Nup214 |
nucleoporin 214 |
decreases expression |
ISO |
lycopene results in decreased expression of NUP214 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 3:15,255,111...15,340,568
Ensembl chr 3:15,255,119...15,340,568
|
|
G |
Nup62 |
nucleoporin 62 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NUP62 mRNA] |
CTD |
PMID:35917956 |
|
NCBI chr 1:95,298,995...95,314,902
Ensembl chr 1:95,295,526...95,315,174
|
|
G |
P22k15 |
cystatin related protein 2 |
decreases expression |
EXP |
lycopene results in decreased expression of P22K15 mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 3:136,960,300...136,967,358
Ensembl chr 3:136,960,303...136,967,358
|
|
G |
Pah |
phenylalanine hydroxylase |
decreases expression |
ISO |
lycopene results in decreased expression of PAH mRNA |
CTD |
PMID:19555370 |
|
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
lycopene inhibits the reaction [decamethrin results in increased activity of PARP1 protein] |
CTD |
PMID:23076637 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
lycopene inhibits the reaction [[Diethylnitrosamine co-treated with Dietary Fats] results in increased expression of PCNA protein] |
CTD |
PMID:19551842 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 protein] |
CTD |
PMID:36583613 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
multiple interactions |
ISO |
lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of PLA2G2A protein] |
CTD |
PMID:22429818 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions |
EXP |
lycopene inhibits the reaction [Atrazine results in increased secretion of POMC protein modified form] |
CTD |
PMID:27102619 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
Lycopene affects the reaction [Atrazine affects the expression of PPARA mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of PPARA protein] |
CTD |
PMID:36216167 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
ISO |
Lycopene results in increased expression of PPARG mRNA [Lycopene co-treated with Atrazine] results in increased expression of PPARG mRNA |
CTD |
PMID:36216167 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of PRDX1 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx2 |
peroxiredoxin 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of PRDX2 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions increases phosphorylation increases expression |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of PRKAA2 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased phosphorylation of PRKAA2 protein] Lycopene results in increased phosphorylation of PRKAA2 protein Lycopene results in increased expression of PRKAA2 mRNA |
CTD |
PMID:30360616 |
|
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Prkab1 |
protein kinase AMP-activated non-catalytic subunit beta 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of PRKAB1 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr12:40,588,140...40,598,673
Ensembl chr12:40,588,211...40,598,661
|
|
G |
Prkab2 |
protein kinase AMP-activated non-catalytic subunit beta 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of PRKAB2 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 2:185,257,218...185,272,846
Ensembl chr 2:185,257,213...185,269,872
|
|
G |
Prkag2 |
protein kinase AMP-activated non-catalytic subunit gamma 2 |
multiple interactions |
ISO |
Lycopene affects the reaction [Atrazine results in increased expression of PRKAG2 mRNA] |
CTD |
PMID:30360616 |
|
NCBI chr 4:10,010,890...10,252,155
Ensembl chr 4:10,010,890...10,252,142
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
ISO |
lycopene results in decreased expression of PRKDC mRNA |
CTD |
PMID:16886892 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PRKN mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PRKN protein] |
CTD |
PMID:36583613 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of PTGS2 mRNA]; Lycopene inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA] |
CTD |
PMID:28974442 PMID:36216167 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PYCARD mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PYCARD protein] |
CTD |
PMID:36610486 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
increases expression |
ISO |
lycopene results in increased expression of RAD50 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
|
|
G |
Rassf7 |
Ras association domain family member 7 |
increases expression |
ISO |
lycopene results in increased expression of RASSF7 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 1:196,319,600...196,323,787
Ensembl chr 1:196,320,902...196,323,770
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions decreases phosphorylation |
ISO |
lycopene inhibits the reaction [Genistein results in increased phosphorylation of and results in decreased activity of RB1 protein]; lycopene inhibits the reaction [IGF1 protein results in increased phosphorylation of RB1 protein] lycopene results in decreased phosphorylation of RB1 protein |
CTD |
PMID:16565789 PMID:17051425 PMID:17337101 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rdx |
radixin |
decreases expression |
ISO |
lycopene results in decreased expression of RDX mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased phosphorylation of RELA protein] |
CTD |
PMID:36583613 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
multiple interactions |
EXP |
[Glucose co-treated with Lycopene] results in increased expression of RIPK1 mRNA |
CTD |
PMID:38444079 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
multiple interactions |
EXP |
[Glucose co-treated with Lycopene] results in increased expression of RIPK3 mRNA |
CTD |
PMID:38444079 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Rps6ka1 |
ribosomal protein S6 kinase A1 |
decreases expression |
ISO |
lycopene results in decreased expression of RPS6KA1 protein |
CTD |
PMID:17337101 |
|
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
|
|
G |
Rps6ka3 |
ribosomal protein S6 kinase A3 |
decreases expression |
ISO |
lycopene results in decreased expression of RPS6KA3 protein |
CTD |
PMID:17337101 |
|
NCBI chr X:35,517,306...35,623,296
Ensembl chr X:35,517,306...35,623,207
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
increases expression |
ISO |
lycopene results in increased expression of RRM2 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
Sbp |
spermine binding protein |
decreases expression |
EXP |
lycopene results in decreased expression of SBP mRNA |
CTD |
PMID:15084515 |
|
NCBI chr10:12,946,036...12,968,439
Ensembl chr10:12,946,036...12,968,439
|
|
G |
Scgb1d2 |
secretoglobin, family 1D, member 2 |
decreases expression |
EXP |
lycopene results in decreased expression of SCGB1D2 mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 1:206,228,546...206,233,587
Ensembl chr 1:206,228,778...206,231,785
|
|
G |
Scgb1d4 |
secretoglobin family 1D member 4 |
decreases expression |
EXP |
lycopene results in decreased expression of SCGB1D4 mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 1:206,330,454...206,333,329
Ensembl chr 1:206,330,454...206,333,329
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of SELE mRNA]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of SELE protein]; lycopene inhibits the reaction [TNF protein results in increased expression of SELE mRNA] |
CTD |
PMID:22429818 PMID:25551565 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Selenop |
selenoprotein P |
decreases expression |
ISO |
lycopene results in decreased expression of SELENOP mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Selenos |
selenoprotein S |
increases expression |
EXP |
Lycopene results in increased expression of SELENOS mRNA |
CTD |
PMID:38444079 |
|
NCBI chr 1:119,659,779...119,669,546
Ensembl chr 1:119,659,751...119,669,833
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
lycopene inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT1 protein] |
CTD |
PMID:28974442 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Skap2 |
src kinase associated phosphoprotein 2 |
decreases expression |
ISO |
lycopene results in decreased expression of SKAP2 mRNA |
CTD |
PMID:19555370 |
|
NCBI chr 4:80,948,832...81,100,900
Ensembl chr 4:80,950,580...81,100,891
|
|
G |
Smad3 |
SMAD family member 3 |
increases expression |
ISO |
lycopene results in increased expression of SMAD3 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smc1a |
structural maintenance of chromosomes 1A |
decreases expression |
ISO |
lycopene results in decreased expression of SMC1A mRNA |
CTD |
PMID:16886892 |
|
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions increases expression |
ISO EXP |
Lycopene inhibits the reaction [Atrazine results in increased expression of SOD1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SOD1 mRNA]; Lycopene promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SOD1 protein] Lycopene results in increased expression of SOD1 mRNA [Glucose co-treated with Lycopene] results in increased expression of SOD1 mRNA |
CTD |
PMID:35917956 PMID:36216167 PMID:36610486 PMID:38444079 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
ISO EXP |
Lycopene inhibits the reaction [Atrazine results in increased expression of SOD2 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SOD2 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SOD2 protein] [Glucose co-treated with Lycopene] results in increased expression of SOD2 mRNA Lycopene results in increased expression of SOD2 mRNA |
CTD |
PMID:35917956 PMID:36216167 PMID:36610486 PMID:38444079 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of SOD3 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SOD3 mRNA] |
CTD |
PMID:35917956 PMID:36216167 PMID:36610486 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO EXP |
Lycopene inhibits the reaction [Atrazine results in increased expression of SQSTM1 mRNA alternative form]; Lycopene inhibits the reaction [Atrazine results in increased expression of SQSTM1 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of SQSTM1 protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SQSTM1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SQSTM1 protein] [Glucose co-treated with Lycopene] results in increased expression of SQSTM1 mRNA |
CTD |
PMID:30360616 PMID:36583613 PMID:38444079 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression |
EXP |
lycopene results in decreased expression of SRD5A1 mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP |
lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of STAR protein]; lycopene inhibits the reaction [decamethrin results in decreased expression of STAR mRNA] |
CTD |
PMID:19071209 PMID:23076637 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases expression |
ISO |
lycopene results in increased expression of STAT3 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of STING1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of STING1 protein] |
CTD |
PMID:36583613 |
|
NCBI chr18:27,332,119...27,338,371
Ensembl chr18:27,332,119...27,338,335
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased phosphorylation of TBK1 protein] |
CTD |
PMID:36583613 |
|
NCBI chr 7:57,077,830...57,110,868
Ensembl chr 7:57,077,830...57,110,892
|
|
G |
Tff1 |
trefoil factor 1 |
decreases expression |
ISO |
lycopene results in decreased expression of TFF1 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
decreases expression |
ISO |
lycopene results in decreased expression of TFPI2 mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
|
|
G |
Tgfa |
transforming growth factor alpha |
increases expression |
ISO |
lycopene results in increased expression of TGFA mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tlr2 |
toll-like receptor 2 |
multiple interactions |
ISO |
lycopene inhibits the reaction [HMGB1 protein results in increased expression of TLR2 protein]; lycopene inhibits the reaction [Lipopolysaccharides results in increased expression of TLR2 protein] |
CTD |
PMID:22429818 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
lycopene inhibits the reaction [HMGB1 protein results in increased expression of TLR4 protein]; lycopene inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] Lycopene affects the reaction [Atrazine affects the expression of TLR4 mRNA] |
CTD |
PMID:22429818 PMID:36216167 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP ISO |
[Lycopene co-treated with Diethylnitrosamine] results in increased expression of TNF mRNA; Lycopene inhibits the reaction [Oxaliplatin results in increased expression of TNF protein] [Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; [Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]; [Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; [Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; [Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; [Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of TNF mRNA]; [Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of TNF protein]; lycopene inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; lycopene inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]; lycopene inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; lycopene inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; lycopene inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; lycopene inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; lycopene inhibits the reaction [TNF protein results in increased expression of TNF mRNA]; lycopene promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] Lycopene inhibits the reaction [Atrazine results in increased expression of TNF mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of TNF protein]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TNF mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TNF protein]; Lycopene inhibits the reaction [Galactose results in increased expression of TNF protein]; Lycopene inhibits the reaction [Zearalenone results in increased expression of TNF] |
CTD |
PMID:19551842 PMID:22429818 PMID:25551565 PMID:25682699 PMID:28974442 PMID:32544411 PMID:36216167 PMID:36583613 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression multiple interactions |
ISO |
lycopene results in decreased expression of TP53 mRNA Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TP53 mRNA] |
CTD |
PMID:16886892 PMID:36583613 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Atrazine results in increased expression of TRAF6 mRNA]; Lycopene inhibits the reaction [Atrazine results in increased expression of TRAF6 protein] |
CTD |
PMID:36216167 |
|
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of TSHB protein] |
CTD |
PMID:33592256 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions |
ISO |
Lycopene affects the reaction [Atrazine affects the expression of TXN1 mRNA] |
CTD |
PMID:36216167 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txn2 |
thioredoxin 2 |
multiple interactions decreases expression |
ISO |
Lycopene inhibits the reaction [Atrazine results in decreased expression of TXN2 mRNA] Lycopene results in decreased expression of TXN2 mRNA |
CTD |
PMID:36216167 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 mRNA]; lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 protein] |
CTD |
PMID:22429818 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vcp |
valosin-containing protein |
increases expression |
ISO |
lycopene results in increased expression of VCP mRNA |
CTD |
PMID:16886892 |
|
NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of VEGFA protein] |
CTD |
PMID:33592256 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions |
ISO |
Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of XBP1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of XBP1 protein] |
CTD |
PMID:36583613 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|